On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective [PDF]
Frontiers in Psychology, 2023 The so-called neurorights are emerging human rights, or rather reconfigurations of already existing human rights, seeking to address the impact of the possible misuse of neurotechnologies, which have the potential to become more invasive and harmful in ...
María Isabel Cornejo-Plaza +1 more
doaj +2 more sources
A Preliminary Investigation of a Conceptual Framework of Performance Enhancement Across Different Life Domains [PDF]
SportsThe use of chemically assisted performance enhancement (CAPE) substances has become a prominent trend in today’s competitive societies. Although evidence suggests that CAPE behaviors across different life domains share common characteristics, no ...
Lida Skoufa +3 more
doaj +2 more sources
Focus on neuroenhancement: a systematic review and its ethical implications [PDF]
European Psychiatry, 2022 Introduction Pharmacological and cognitive neuroenhancement refer to the non-medical use of prescription drugs, alcohol, illegal drugs, or the so-called soft enhancers, to enhance cognition, mood, work or school performance, or to promote pro-social ...
L. Massa +6 more
doaj +2 more sources
Neurofeedback on twitter: Evaluation of the scientific credibility and communication about the technique [PDF]
Heliyon, 2023 Neurofeedback is a popular technique to induce neuroplasticity with a controversial reputation. The public discourse on neurofeedback, as a therapeutic and neuroenhancement technique, encompasses scientific communication, therapeutic expectations and ...
Silvia Erika Kober +2 more
doaj +2 more sources
The is and ought of the Ethics of Neuroenhancement: Mind the Gap
Frontiers in Psychology, 2016 Ethical perspectives on the use of stimulants to enhance human cognitive performance (neuroenhancement) are polarized between conservative and liberal theories offering opposing advice on whether individuals have a right to use neuroenhancers and what ...
Cynthia Forlini +2 more
exaly +3 more sources
Skin Lesions as Signs of Neuroenhancement in Sport [PDF]
Brain SciencesBackground: Neuroenhancement in sports, through pharmacological and non-pharmacological methods, is a complex and highly debated topic with no definitive regulatory framework established by the World Anti-Doping Agency (WADA).
Sorana-Cristiana Popescu +3 more
doaj +2 more sources
Race, intelligence and genetics: colonialism in the era of neurotechnology [PDF]
Frontiers in Public HealthUnequal access is not the only or even the main ethical challenge concerning neurotechnological advancements in the Global South. Epistemic sanctioned discourses on cognitive abilities are powerful and have been used to subdue and marginalize people ...
Monique Pyrrho
doaj +2 more sources
Neuroenhancement and mental health in students from four faculties – a cross-sectional questionnaire study [PDF]
GMS Journal for Medical EducationBackground: Students face great challenges at the beginning of and during their studies. Competitive experience, exam anxiety, and especially the new performance requirements often cause test anxiety and stressful experiences. The extent of substance use
Hajduk, Maurice +3 more
doaj +2 more sources
Visual Field Improvement by Standardized Automated Perimetry Following Panmacular Subthreshold Diode Micropulse Laser (SDM) in Open-Angle Glaucoma and Other Optic Atrophies [PDF]
DiagnosticsPurpose: To assess the effect of subthreshold diode micropulse laser (SDM) on visual fields (VF) by standardized automated perimetry (SAP) in open-angle glaucoma (OAG) and other non-glaucomatous optic atrophies (OA).
Jeffrey K. Luttrull, Sathy V. Bhavan
doaj +2 more sources
Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma [PDF]
Ophthalmology Science, 2023 Purpose: To assess the safety and efficacy of a ciliary neurotrophic factor (CNTF) intraocular implant on neuroprotection and neuroenhancement in glaucoma. Design: Open-label, prospective, phase I clinical trial.
Jeffrey L. Goldberg, MD, PhD +5 more
doaj +2 more sources